Partner With Us NRI

Max Healthcare Institute Ltd share Price Today

Company details

6M Return 56.84%
1Y Return 97.52%
Mkt Cap.(Cr) 84,592.59
Volume 2,913,519
Div Yield 0.11%
OI Chg %
Volume 2,913,519

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Max Healthcare Institute announced Q3FY24 results:

  • Gross Revenue stood at Rs 1,779 crore for Q3FY24, 14% growth YoY
  • Network Operating EBITDA was Rs 471 crore, growth of 12% YoY
  • Operating Margin stood at 27.9% versus 28.3% in Q3FY23 and 28.7% in Q2FY24
  • EBITDA per bed improved to Rs 75.6 lakhs in Q3FY24, from Rs 66.9 lakhs in Q3FY23 and Rs 75.0 lakhs in Q2FY24
  • PAT grew by 26% YoY to Rs 338 crore in Q3FY24 Vs Rs 269 crore in Q3FY23 and Rs 338 crore in Q2FY24
  • Cash from Operations was Rs 226 crore in Q3FY24 of this Rs 137 crore was spent towards ongoing capacity expansion projects & Rs 97 crore was paid as dividend; Net Cash as of Dec 31, 2023, stood at Rs 1,295 crore
  • Bed occupancy in Q3FY24 stood at 73% and OBDs were lower by ~1% YoY
  • ARPOB improved to Rs 76.8k in Q3FY24 vs. Rs 66.8k in Q3FY23 and 74.6K in Q2FY24
  • Free treatment provided to 36,695 patients in OPD and 1,249 patients in IPD from the economically weaker sections
  • YoY growth in EBITDA was impacted due to movement in provision for doubtful debts, reversal of provision for Phantom Stock Plan in Q3FY23, GST costs on variable fees and one-time litigation costs, with an overall impact of ~Rs 25 crore on a like-to-like basis

Commenting on Q3 results, Abhay Soi, Chairman, and Managing Director, Max Healthcare Institute, said: “We continue to witness positive trends on all parameters like ARPOB, EBITDA per bed, etc. even during this quarter, translating into revenue and profitability growth, despite expected softness in occupancies due to festive season. Further, our entry into central UP through the acquisition of Sahara Hospital will strengthen our presence in Northern India and will act as a stepping stone in growing Max Healthcare’s presence in the region.”


Result PDF

View Other Company Results

Max Healthcare Institute Ltd shares SWOT Analysis

Strengths (15)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Strong Annual EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years

Weakness (0)

Data not found

Opportunity (3)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength
  • High Volume, High Gain

Threats (4)

  • Promoter decreasing their shareholding
  • Big Deal (Insider and SAST) sells last month greater than 1% of total shares
  • Companies with growing costs YoY for long term projects

Resistance and support

R1 892.8
R2 915.2
R3 935.6


S1 850.0
S2 829.6
S3 807.2
Delivery and volume
GOVERNMENT OF SINGAPORE Bulk Purchase 2023-05-31 549.53 6660226 NSE
BNP PARIBAS ARBITRAGE Bulk Purchase 2023-05-31 546.08 20946 NSE
BNP PARIBAS ARBITRAGE Bulk Sell 2023-05-31 546.56 9033634 NSE
Name Category Shares
Abhay Soi PROMOTER 23.74%


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Max Healthcare Institute Ltd Stocks COMPARISON

Financials( in Cr) Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Global Health Ltd Fortis Healthcare Ltd Narayana Hrudayalaya Ltd
Price 870.45 6,406.55 1,398.30 431.45 1,288.40
% Change 0.71 -1.28 -1.92 -0.54 -1.88
Mcap Cr 84,592.59 92,116.58 37,534.15 32,572.66 26,329.87
Revenue TTM Cr 4,831.37 16,612.50 2,694.25 6,537.06 4,524.77
Net Profit TTM Cr 1,103.51 887.50 326.08 632.98 606.57
PE TTM 79.91 116.84 83.06 60.71 34.16
1 Year Return 97.52 51.20 183.11 68.73 66.87
ROCE 13.85 14.16 16.49 7.51 29.27
ROE 16.12 15.04 16.13 6.79 33.51

Equity Capital: 7,409.54 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,771.53 7,735.64
LAST 3M 82,392.14 52,275.07
LAST 6M 132,482.07 84,624.18
LAST 12M 206,189.80 211,987.34

Max Healthcare Institute Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Max Healthcare Institute Limited is an India-based healthcare company with a market capitalisation of Rs. 35,729.35 crore as of April 5, 2022. It owns and operates hospital chains across Delhi, National Capital Region (NCR), North India, and Mumbai. The company was incorporated on June 18, 2001, and its revenue touched Rs. 2,505 crore in the financial year 2021-22. Max Healthcare shares are listed on the Bombay Stock Exchange (BSE) as well as the National Stock Exchange (NSE) under the number 543220 and scrip code MAXHEALTH, respectively.

    Max Healthcare Limited is an Indian company that runs a chain of hospitals that specialise in providing treatment for cancer, oncology, neurosciences, cardiac sciences, orthopaedics, liver transplant, kidney transplant, bone marrow transplant, nephrology, and laparoscopic surgery, among others. The company also provides pathology and diagnostic services to its patients through a variety of channels, including self-owned and third-party diagnostic centres. The majority of Max Healthcare hospitals are located in Delhi, the National Capital Region (NCR), northern parts of India, and western Mumbai.

    The company was founded in 2000 and its first hospital was opened in the same year in South Delhi’s Panchsheel Park. It opened two more hospitals in 2002 in Northwest Delhi and Eastern Delhi. In 2011, Max Healthcare Limited signed a public-private partnership agreement with the government of Punjab to set up two hospitals in Mohali and Bathinda. It witnessed acquisitions and mergers with several hospitals during the process, including Pushpanjali Crosslay Hospital in Vaishali, Saket City Hospital in Saket, Radiant Lifecare, and the iconic Nanavati Hospital in Mumbai, and soon became the second-largest healthcare company in India in terms of revenues. The total number of employees of this company stood at 3,783 in 2020. The Managing Director of the company, Abhay Soi, holds 23.1% shares in the company, other promoters 37.54%, FII investors 16.67%, public investors 6.97%, and 15.58% are invested in mutual funds.

    As of April 5, 2022, Max Healthcare’s share price closed at Rs. 369.40 at the NSE. The 52-week high for Max Health share is Rs. 458.05 and the 52-week low is Rs. 212.00. Max Healthcare shares have provided one-year returns of 61.06%.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543220
Book Closure Date (Month) :
BSE Group : A
ISIN : INE027H01010

FAQ’s on Max Healthcare Institute Ltd Shares

You can buy Max Healthcare Institute Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Max Healthcare Institute Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 12, 2024 04:05 PM the closing price of Max Healthcare Institute Ltd was ₹ 870.45.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 12, 2024 04:05 PM, the market cap of Max Healthcare Institute Ltd stood at ₹ 84,592.59.

The latest PE ratio of Max Healthcare Institute Ltd as of Apr 12, 2024 04:05 PM is 79.91

The latest PB ratio of Max Healthcare Institute Ltd as of Apr 12, 2024 04:05 PM is 0.09

The 52-week high of Max Healthcare Institute Ltd share price is ₹ 910.00 while the 52-week low is ₹ 435.05

Download Our

Download App
market app